Cellavita Executive Summary
NestaCell®: A Breakthrough Therapy Offering Hope for ALS Patients
Advances in Cellular and Cell-Free Therapy Medicinal Products for Huntington Disease Treatment
Brain-Derived Neurotrophic Factor and Stem Cell-Based Technologies in Huntington’s Disease Therapy
Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington’s Disease 3-NP Rat Model
Unique Transcriptional Signatures Observed in Stem Cells from the Dental Pulp of Deciduous Teeth Produced on a Large Scale